Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor Growth”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01550523
What this trial is testing

Pilot Immunotherapy Trial for Recurrent Malignant Gliomas

Who this might be right for
Malignant Glioma of Brain
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 13
Testing effectiveness (Phase 2)Ended earlyNCT03822117
What this trial is testing

Efficacy and Safety of Pemigatinib in Previously Treated Locally Advanced/Metastatic or Surgically Unresectable Solid Tumor Malignancies Harboring Activating FGFR Mutations or Translocations (FIGHT-207)

Who this might be right for
Solid Tumor Malignancy
Incyte Corporation 111
Testing effectiveness (Phase 2)Looking for participantsNCT06500208
What this trial is testing

Neoadjuvant Adebrelimab and Chemotherapy in High-rish ER+/HER2- BC

Who this might be right for
Breast Cancer
Shanghai Jiao Tong University School of Medicine 48
Not applicableUnknownNCT02119559
What this trial is testing

Circulating Tumor Cells as an Early Predictive head-and -Neck Squamous-cell Carcinoma

Who this might be right for
Metastatic Head-and-neck Squamous-cell Carcinoma
University Hospital, Montpellier 115
Early research (Phase 1)Study completedNCT02834780
What this trial is testing

Phase 1 Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of H3B-6527 in Participants With Advanced Hepatocellular Carcinoma

Who this might be right for
Advanced Hepatocellular CarcinomaHepatocellular CarcinomaLiver Cancer+3 more
H3 Biomedicine Inc. 128
Testing effectiveness (Phase 2)Study completedNCT02421185
What this trial is testing

Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-42756493 (Erdafitinib) in Participants With Advanced Hepatocellular Carcinoma

Who this might be right for
Carcinoma, Hepatocellular
Janssen Research & Development, LLC 53
Early research (Phase 1)Looking for participantsNCT06934889
What this trial is testing

Study of ABBV-637 or ABBV-155 With ERAS-801 for People With Glioblastoma

Who this might be right for
GlioblastomaGliosarcoma
Memorial Sloan Kettering Cancer Center 60
Testing effectiveness (Phase 2)Looking for participantsNCT07222215
What this trial is testing

PhII Randomized CAPecitabine + ELAcestrant vs. Capecitabine Alone in ER+ Breast Cancer (CAPELA)

Who this might be right for
Estrogen-receptor-positive Breast CancerMetastatic Breast CancerBreast Cancer+6 more
Kristina A. Fanucci 297
Not applicableStudy completedNCT06321510
What this trial is testing

Learn About Dacomitinib in Patients With Non-small Cell Lung Cancer.

Who this might be right for
Lung Cancer
Pfizer 29
Not applicableStudy completedNCT04206787
What this trial is testing

The Study Observes Afatinib as First-line Treatment in Patients With Epidermal Growth Factor Receptor (EGFR) Mutation-positive Advanced Non-small Cell Lung Cancer

Who this might be right for
Non-squamous, Non-Small Cell Lung Cancer
Boehringer Ingelheim 72
Not applicableLooking for participantsNCT06115122
What this trial is testing

PEPPI Study: Identification of Women at Risk for Placental Dysfunction

Who this might be right for
Pre-EclampsiaIntrauterine Growth RestrictionPolycystic Ovary Syndrome+4 more
Oulu University Hospital 3,000
Testing effectiveness (Phase 2)Ended earlyNCT03431311
What this trial is testing

T Cell Receptor Based Therapy of Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Oslo University Hospital 1
Early research (Phase 1)Study completedNCT02789345
What this trial is testing

Ramucirumab (LY3009806) or Necitumumab (LY3012211) Plus Osimertinib in Participants With Lung Cancer

Who this might be right for
Non-small Cell Lung Cancer
Eli Lilly and Company 29
Testing effectiveness (Phase 2)Study completedNCT00139230
What this trial is testing

Combination Chemotherapy for Locally Advanced Squamous Cell Carcinoma of the Head and Neck

Who this might be right for
Squamous Cell CarcinomaCarcinoma of Head/Neck
Dana-Farber Cancer Institute 30
Not applicableStudy completedNCT02246192
What this trial is testing

Use of Plasma Rich in Growth Factors (PRGF) in Pilonidal Sinus Excision

Who this might be right for
Pilonidal Sinus
Hospital Quiron Sagrado Corazon 51
Testing effectiveness (Phase 2)Active Not RecruitingNCT05801029
What this trial is testing

Investigate Safety and Efficacy of Osimertinib and Amivantamab in Participants With Non-small Cell Lung Cancer With Common Epidermal Growth Factor Receptor Mutations

Who this might be right for
Non-Small Cell Lung Cancer (NSCLC)
AstraZeneca 60
Testing effectiveness (Phase 2)Study completedNCT01152437
What this trial is testing

BIBW 2992 (Afatinib) in Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Neoplasms
Boehringer Ingelheim 94
Not applicableLooking for participantsNCT06106477
What this trial is testing

Impact of Intermittent Fasting on Biomarkers of Inflammation and Health-Related Quality of Life: A Feasibility Trial for Women With HR+/HER2- Early Breast Cancer

Who this might be right for
Breast Cancer
Medical College of Wisconsin 20
Not applicableStudy completedNCT03421912
What this trial is testing

Satisfaction and Quality of Life Comparison Between Patients Using Cicaplast Baume B5 Versus Dexeryl for the Management of Cutaneous Toxicities Induced by Epidermal Growth Factor Receptor Inhibitors (iEGFR)

Who this might be right for
Head and Neck Squamous Cell CarcinomaColorectal CancerNon Small Cell Lung Cancer+1 more
Centre Leon Berard 102
Testing effectiveness (Phase 2)Study completedNCT04368507
What this trial is testing

To Evaluate the Safety, Tolerability, Pharmacokinetics and Antitumor Activity of YYB101 With Irinotecan, Patients Who Are Metastatic or Recurrent Colorectal Cancer Patients

Who this might be right for
Colorectal Cancer MetastaticColorectal Cancer Recurrent
CellabMED 35
Next Page